Ignite Creation Date:
2024-05-05 @ 11:16 PM
Last Modification Date:
2024-10-26 @ 10:31 AM
Study NCT ID:
NCT01295112
Status:
COMPLETED
Last Update Posted:
2017-10-18
First Post:
2011-02-10
Brief Title:
Effect of Ozurdex 07 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
Sponsor:
Texas Retina Associates
Organization:
Texas Retina Associates
Organization Data
Organization:
Texas Retina Associates
Class:
OTHER
Study ID:
TRA-OZAB-11-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Texas Retina Associates
Lead Sponsor Class:
OTHER
Responsible Party:
Karl Csaky
Responsible Party Title:
Prinicipal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Texas Retina Associates
Old Name:
None
Old Organization:
None